Impact of Two Measures of Micrometastatic Disease on Clinical Outcomes in Patients with Newly Diagnosed Ewing Sarcoma: A Report from the Children's Oncology Group.

Saved in:
Bibliographic Details
Title: Impact of Two Measures of Micrometastatic Disease on Clinical Outcomes in Patients with Newly Diagnosed Ewing Sarcoma: A Report from the Children's Oncology Group.
Authors: Vo KT; Department of Pediatrics, UCSF Benioff Children's Hospital, University of California, San Francisco School of Medicine, San Francisco, California., Edwards JV; Department of Pediatrics, Walter Reed Army Medical Center, Washington, DC., Epling CL; Division of Experimental Medicine Core Immunology Laboratory, UCSF Benioff Children's Hospital, University of California, San Francisco School of Medicine, San Francisco, California., Sinclair E; Division of Experimental Medicine Core Immunology Laboratory, UCSF Benioff Children's Hospital, University of California, San Francisco School of Medicine, San Francisco, California., Hawkins DS; Division of Hematology/Oncology, Seattle Children's Hospital, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington., Grier HE; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts., Janeway KA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts., Barnette P; Department of Pediatric Hematology/Oncology, Center for Children's Cancer Research, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., McIlvaine E; Department of Preventative Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California., Krailo MD; Department of Preventative Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California., Barkauskas DA; Department of Preventative Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California., Matthay KK; Department of Pediatrics, UCSF Benioff Children's Hospital, University of California, San Francisco School of Medicine, San Francisco, California., Womer RB; Department of Pediatrics, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Gorlick RG; Division of Pediatric Hematology/Oncology, Children's Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, New York., Lessnick SL; Center for Childhood Cancer and Blood Disorders at Nationwide Children's Hospital and the Division of Hematology, Oncology, and BMT at The Ohio State University, Columbus, Ohio., Mackall CL; Pediatric Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., DuBois SG; Department of Pediatrics, UCSF Benioff Children's Hospital, University of California, San Francisco School of Medicine, San Francisco, California. steven_dubois@dfci.harvard.edu.
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2016 Jul 15; Vol. 22 (14), pp. 3643-50. Date of Electronic Publication: 2016 Feb 09.
Publication Type: Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1557-3265
DOI:10.1158/1078-0432.CCR-15-2516